González-Dominguez et al.51demonstrated the deficit of several acylcarnitines, including C3, in the brain (hippocampus, cortex, and cerebellum) of APP/PS1 transgenic mouse model of Alzheimer’s disease. This evidence concerns the gene APP and Alzheimer disease.